NIVOLUMAB-RMBW 12 MG/ML / RELATLIMAB-RMBW 4 MG/ML INJECTION [OPDUALAG]

Side Effects & Adverse Event Reports


View Chart Data

122.5K

Adverse Events

378.7K

Side Effects

2013

Data Starting In

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on NIVOLUMAB-RMBW 12 MG/ML / RELATLIMAB-RMBW 4 MG/ML INJECTION [OPDUALAG].

Understanding the potential Side Effects and Adverse Events of NIVOLUMAB-RMBW 12 MG/ML / RELATLIMAB-RMBW 4 MG/ML INJECTION [OPDUALAG] is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how NIVOLUMAB-RMBW 12 MG/ML / RELATLIMAB-RMBW 4 MG/ML INJECTION [OPDUALAG] may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about NIVOLUMAB-RMBW 12 MG/ML / RELATLIMAB-RMBW 4 MG/ML INJECTION [OPDUALAG] are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for NIVOLUMAB-RMBW 12 MG/ML / RELATLIMAB-RMBW 4 MG/ML INJECTION [OPDUALAG]?

    SymPedia shows NIVOLUMAB-RMBW 12 MG/ML / RELATLIMAB-RMBW 4 MG/ML INJECTION [OPDUALAG] adverse event reports for 122,478.

  • How many side effects have been reported for NIVOLUMAB-RMBW 12 MG/ML / RELATLIMAB-RMBW 4 MG/ML INJECTION [OPDUALAG]?

    SymPedia shows NIVOLUMAB-RMBW 12 MG/ML / RELATLIMAB-RMBW 4 MG/ML INJECTION [OPDUALAG] side effect reports for 378,735.

  • What year does the NIVOLUMAB-RMBW 12 MG/ML / RELATLIMAB-RMBW 4 MG/ML INJECTION [OPDUALAG] reporting data start?

    SymPedia reporting data on this page starts in 2013.

  • What years are included in the yearly chart for NIVOLUMAB-RMBW 12 MG/ML / RELATLIMAB-RMBW 4 MG/ML INJECTION [OPDUALAG]?

    SymPedia yearly chart data on this page covers 2013 to 2025.